Skip to main content
Contact Us
Subscribe
E-Edition
46°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2024
Archives
2025 Calendar Photos
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Adamas Pharmaceuticals, Inc.
Adamas Announces New Employment Inducement Grants
October 08, 2021
From
Adamas Pharmaceuticals, Inc.
Via
Business Wire
Adamas Named 2021 Finalist in the New Therapeutics Category of the UCSF Health Awards
October 01, 2021
From
Adamas Pharmaceuticals, Inc.
Via
Business Wire
Adamas Announces GOCOVRI Presentations at the Upcoming International Parkinson and Movement Disorder Society’s (MDS) Congress
September 16, 2021
From
Adamas Pharmaceuticals, Inc.
Via
Business Wire
Adamas Announces New Employment Inducement Grants
September 10, 2021
From
Adamas Pharmaceuticals, Inc.
Via
Business Wire
Adamas to Present at Upcoming September Investor Conferences
August 30, 2021
From
Adamas Pharmaceuticals, Inc.
Via
Business Wire
Adamas Announces New Employment Inducement Grant
August 13, 2021
From
Adamas Pharmaceuticals, Inc.
Via
Business Wire
Adamas Reports Second Quarter 2021 Financial Results
August 09, 2021
From
Adamas Pharmaceuticals, Inc.
Via
Business Wire
Adamas to Announce Second Quarter Financial Results and Host Conference Call on August 9, 2021
August 02, 2021
From
Adamas Pharmaceuticals, Inc.
Via
Business Wire
Adamas Announces Issuance of New Patents for GOCOVRI and ADS-4101
July 22, 2021
From
Adamas Pharmaceuticals, Inc.
Via
Business Wire
Adamas Announces New Employment Inducement Grant
July 09, 2021
From
Adamas Pharmaceuticals, Inc.
Via
Business Wire
Adamas to Present at Upcoming William Blair Biotech Focus Conference
July 08, 2021
From
Adamas Pharmaceuticals, Inc.
Via
Business Wire
Adamas to Present at Upcoming SVB Leerink CNS Forum
June 23, 2021
From
Adamas Pharmaceuticals, Inc.
Via
Business Wire
Adamas Announces New Employment Inducement Grant
June 11, 2021
From
Adamas Pharmaceuticals, Inc.
Via
Business Wire
New Data Analysis Supports GOCOVRI as an Important Treatment for Motor Complications for People With Parkinson’s Disease
June 10, 2021
From
Adamas Pharmaceuticals, Inc.
Via
Business Wire
Adamas to Present at Upcoming June Conferences
May 27, 2021
From
Adamas Pharmaceuticals, Inc.
Via
Business Wire
Adamas Reports First Quarter 2021 Financial Results
May 10, 2021
From
Adamas Pharmaceuticals, Inc.
Via
Business Wire
Adamas Announces New Employment Inducement Grant
May 07, 2021
From
Adamas Pharmaceuticals, Inc.
Via
Business Wire
Adamas to Present at Upcoming BofA Conference
April 29, 2021
From
Adamas Pharmaceuticals, Inc.
Via
Business Wire
Adamas Launches “Picture More Time” Campaign to Raise Awareness and Understanding of the Impact of OFF Time and Dyskinesia for People With Parkinson’s Disease and Care Partners
April 27, 2021
From
Adamas Pharmaceuticals, Inc.
Via
Business Wire
Adamas to Announce First Quarter Financial Results and Host Conference Call on May 10, 2021
April 26, 2021
From
Adamas Pharmaceuticals, Inc.
Via
Business Wire
Survey data detailing impact of OFF time and dyskinesia in people affected by Parkinson’s disease presented at American Academy of Neurology (AAN) Annual Meeting
April 19, 2021
From
Adamas Pharmaceuticals, Inc.
Via
Business Wire
Adamas Announces Two Presentations for the American Academy of Neurology 73rd Annual Meeting
April 15, 2021
From
Adamas Pharmaceuticals, Inc.
Via
Business Wire
Adamas to Present at Upcoming Needham Conference
April 07, 2021
From
Adamas Pharmaceuticals, Inc.
Via
Business Wire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.